Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma
The need for cost-effective and reliable early diagnostic tools for hepatocellular carcinoma (HCC) is more than ever of great interest, as incidence rates are on the rise globally and two thirds of the patients are diagnosed with HCC in advanced stages. Alpha-fetoprotein (AFP), the marker that is currently in widespread use for HCC, lacks sensitivity […]